RPRX logo

Royalty Pharma (RPRX) Interest expense

annual interest expense:

$225.51M+$38.33M(+20.47%)
December 31, 2024

Summary

  • As of today (May 21, 2025), RPRX annual interest expense is $225.51 million, with the most recent change of +$38.33 million (+20.47%) on December 31, 2024.
  • During the last 3 years, RPRX annual interest expense has risen by +$59.37 million (+35.73%).
  • RPRX annual interest expense is now -19.45% below its all-time high of $279.96 million, reached on December 31, 2018.

Performance

RPRX Interest expense Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRPRXincome statement metrics

quarterly interest expense:

$65.26M-$500.00K(-0.76%)
March 31, 2025

Summary

  • As of today (May 21, 2025), RPRX quarterly interest expense is $65.26 million, with the most recent change of -$500.00 thousand (-0.76%) on March 31, 2025.
  • Over the past year, RPRX quarterly interest expense has increased by +$21.03 million (+47.54%).
  • RPRX quarterly interest expense is now -5.65% below its all-time high of $69.17 million, reached on June 30, 2019.

Performance

RPRX quarterly interest expense Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRPRXincome statement metrics

TTM interest expense:

$246.54M+$21.03M(+9.33%)
March 31, 2025

Summary

  • As of today (May 21, 2025), RPRX TTM interest expense is $246.54 million, with the most recent change of +$21.03 million (+9.33%) on March 31, 2025.
  • Over the past year, RPRX TTM interest expense has increased by +$62.07 million (+33.65%).
  • RPRX TTM interest expense is now -8.20% below its all-time high of $268.57 million, reached on December 31, 2019.

Performance

RPRX TTM interest expense Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRPRXincome statement metrics

Interest expense Formula

Interest Expense = Carrying Value of Debt X Effective Interest Rate

RPRX Interest expense Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+20.5%+47.5%+33.6%
3 y3 years+35.7%+38.7%+40.3%
5 y5 years-16.0%+21.8%-3.3%

RPRX Interest expense Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+35.7%-1.9%+47.5%at high+40.3%
5 y5-year-16.0%+43.6%-1.9%+107.5%-3.3%+75.0%
alltimeall time-19.4%+43.6%-5.7%+107.5%-8.2%+266.5%

RPRX Interest expense History

DateAnnualQuarterlyTTM
Mar 2025
-
$65.26M(-0.8%)
$246.54M(+9.3%)
Dec 2024
$225.51M(+20.5%)
$65.76M(-1.1%)
$225.51M(+8.9%)
Sep 2024
-
$66.51M(+35.7%)
$207.01M(+11.0%)
Jun 2024
-
$49.01M(+10.8%)
$186.53M(+1.1%)
Mar 2024
-
$44.23M(-6.4%)
$184.47M(-1.5%)
Dec 2023
$187.19M(-0.4%)
$47.26M(+2.7%)
$187.19M(+0.2%)
Sep 2023
-
$46.03M(-2.0%)
$186.89M(-0.5%)
Jun 2023
-
$46.95M(-0.0%)
$187.83M(-0.0%)
Mar 2023
-
$46.95M(-0.0%)
$187.85M(-0.1%)
Dec 2022
$187.96M(+13.1%)
$46.95M(-0.0%)
$187.96M(-0.0%)
Sep 2022
-
$46.98M(+0.0%)
$187.98M(+1.4%)
Jun 2022
-
$46.97M(-0.2%)
$185.33M(+5.4%)
Mar 2022
-
$47.06M(+0.2%)
$175.79M(+5.8%)
DateAnnualQuarterlyTTM
Dec 2021
$166.14M(+5.8%)
$46.97M(+6.0%)
$166.14M(+5.8%)
Sep 2021
-
$44.33M(+18.4%)
$157.01M(+8.9%)
Jun 2021
-
$37.43M(+0.0%)
$144.13M(+2.3%)
Mar 2021
-
$37.41M(-1.1%)
$140.89M(-10.3%)
Dec 2020
$157.06M(-41.5%)
$37.84M(+20.3%)
$157.06M(-14.0%)
Sep 2020
-
$31.44M(-8.0%)
$182.56M(-17.0%)
Jun 2020
-
$34.19M(-36.2%)
$219.91M(-13.7%)
Mar 2020
-
$53.58M(-15.4%)
$254.89M(-5.1%)
Dec 2019
$268.57M(-4.1%)
$63.34M(-7.9%)
$268.57M(+30.9%)
Sep 2019
-
$68.80M(-0.5%)
$205.23M(+50.4%)
Jun 2019
-
$69.17M(+2.8%)
$136.43M(+102.8%)
Mar 2019
-
$67.27M
$67.27M
Dec 2018
$279.96M(+13.2%)
-
-
Dec 2017
$247.34M
-
-

FAQ

  • What is Royalty Pharma annual interest expense?
  • What is the all time high annual interest expense for Royalty Pharma?
  • What is Royalty Pharma annual interest expense year-on-year change?
  • What is Royalty Pharma quarterly interest expense?
  • What is the all time high quarterly interest expense for Royalty Pharma?
  • What is Royalty Pharma quarterly interest expense year-on-year change?
  • What is Royalty Pharma TTM interest expense?
  • What is the all time high TTM interest expense for Royalty Pharma?
  • What is Royalty Pharma TTM interest expense year-on-year change?

What is Royalty Pharma annual interest expense?

The current annual interest expense of RPRX is $225.51M

What is the all time high annual interest expense for Royalty Pharma?

Royalty Pharma all-time high annual interest expense is $279.96M

What is Royalty Pharma annual interest expense year-on-year change?

Over the past year, RPRX annual interest expense has changed by +$38.33M (+20.47%)

What is Royalty Pharma quarterly interest expense?

The current quarterly interest expense of RPRX is $65.26M

What is the all time high quarterly interest expense for Royalty Pharma?

Royalty Pharma all-time high quarterly interest expense is $69.17M

What is Royalty Pharma quarterly interest expense year-on-year change?

Over the past year, RPRX quarterly interest expense has changed by +$21.03M (+47.54%)

What is Royalty Pharma TTM interest expense?

The current TTM interest expense of RPRX is $246.54M

What is the all time high TTM interest expense for Royalty Pharma?

Royalty Pharma all-time high TTM interest expense is $268.57M

What is Royalty Pharma TTM interest expense year-on-year change?

Over the past year, RPRX TTM interest expense has changed by +$62.07M (+33.65%)
On this page